Amedisys Inc
NASDAQ:AMED
Gross Margin
Amedisys Inc
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Gross Margin Across Competitors
Country | US |
Market Cap | 3.1B USD |
Gross Margin |
44%
|
Country | US |
Market Cap | 90.3B EUR |
Gross Margin |
12%
|
Country | US |
Market Cap | 96.4B USD |
Gross Margin |
12%
|
Country | US |
Market Cap | 72B USD |
Gross Margin |
15%
|
Country | US |
Market Cap | 18B USD |
Gross Margin |
28%
|
Country | DE |
Market Cap | 16.1B EUR |
Gross Margin |
23%
|
Country | US |
Market Cap | 15.8B USD |
Gross Margin |
33%
|
Country | DE |
Market Cap | 12.2B EUR |
Gross Margin |
25%
|
Country | DE |
Market Cap | 12.2B EUR |
Gross Margin |
25%
|
Country | US |
Market Cap | 12B USD |
Gross Margin |
32%
|
Country | US |
Market Cap | 9.5B USD |
Gross Margin |
4%
|
Profitability Report
View the profitability report to see the full profitability analysis for Amedisys Inc.
See Also
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Based on Amedisys Inc's most recent financial statements, the company has Gross Margin of 44.4%.